Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851303 · ClinicalTrials.gov registry record · Phase 4
Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
A Phase 4 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT02851303 is a Phase 4 study that has completed, run by University of New Mexico. The registered enrollment target is 61 participants.
The verdict
NCT02851303, a Phase 4 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
This study investigates the use of methadone versus morphine wean for the treatment of neonatal abstinence syndrome for infants exposed to opioids in utero. Half of infants who require pharmacotherapy for NAS will receive a methadone wean, and half will receive a morphine wean. Length of hospital stay, length of treatment and parent satisfaction will be studied.
Interventions
- DRUG Methadone
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851303
The ClinicalTrials.gov registry entry for NCT02851303 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT02851303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02851303 about?
NCT02851303 is a clinical study titled "Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome". This study investigates the use of methadone versus morphine wean for the treatment of neonatal abstinence syndrome for infants exposed to opioids in utero. Half of infants who require pharmacotherapy for NAS will receive a methadone wean, and half will receive a morphine wean. Length of hospital st...
What is the current status of trial NCT02851303?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2016-10. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02851303?
The interventions under investigation include: Methadone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT02851303?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.